These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
541 related articles for article (PubMed ID: 19628153)
1. Novel interferons for treatment of hepatitis C virus. Clark V; Nelson DR Clin Liver Dis; 2009 Aug; 13(3):351-63. PubMed ID: 19628153 [TBL] [Abstract][Full Text] [Related]
2. Mechanism of action of interferon and ribavirin in treatment of hepatitis C. Feld JJ; Hoofnagle JH Nature; 2005 Aug; 436(7053):967-72. PubMed ID: 16107837 [TBL] [Abstract][Full Text] [Related]
4. New therapeutic options for hepatitis C. Waters L; Nelson M Curr Opin Infect Dis; 2006 Dec; 19(6):615-22. PubMed ID: 17075339 [TBL] [Abstract][Full Text] [Related]
5. Interferon-based therapy of hepatitis C. Chevaliez S; Pawlotsky JM Adv Drug Deliv Rev; 2007 Oct; 59(12):1222-41. PubMed ID: 17869375 [TBL] [Abstract][Full Text] [Related]
6. Antiviral resistance and the future landscape of hepatitis C virus infection therapy. Wyles DL J Infect Dis; 2013 Mar; 207 Suppl 1():S33-9. PubMed ID: 23390303 [TBL] [Abstract][Full Text] [Related]
7. Interferon alpha delivery systems for the treatment of hepatitis C. Thitinan S; McConville JT Int J Pharm; 2009 Mar; 369(1-2):121-35. PubMed ID: 19103271 [TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus: prospects for future therapies. Wilkinson T Curr Opin Investig Drugs; 2001 Nov; 2(11):1516-22. PubMed ID: 11763151 [TBL] [Abstract][Full Text] [Related]
9. Future treatment of chronic hepatitis C. Keeffe EB Antivir Ther; 2007; 12(7):1015-25. PubMed ID: 18018759 [TBL] [Abstract][Full Text] [Related]
10. Strategies for hepatitis C therapeutic intervention: now and next. Tan SL; He Y; Huang Y; Gale M Curr Opin Pharmacol; 2004 Oct; 4(5):465-70. PubMed ID: 15351350 [TBL] [Abstract][Full Text] [Related]
11. [Current advances in hepatitis C treatment]. Cisneros-Garza LE Salud Publica Mex; 2011; 53 Suppl 1():S52-60. PubMed ID: 21877074 [TBL] [Abstract][Full Text] [Related]
12. New drugs for hepatitis C virus. Pockros PJ Expert Rev Gastroenterol Hepatol; 2007 Oct; 1(1):145-54. PubMed ID: 19072442 [TBL] [Abstract][Full Text] [Related]
13. Future directions in therapy for chronic hepatitis C. Jensen DM; Ascione A Antivir Ther; 2008; 13 Suppl 1():31-6. PubMed ID: 18432161 [TBL] [Abstract][Full Text] [Related]
15. The interferon sensitivity determining region: all hepatitis C virus isolates are not the same. Herion D; Hoofnagle JH Hepatology; 1997 Mar; 25(3):769-71. PubMed ID: 9049233 [No Abstract] [Full Text] [Related]
16. A mutational shift from domain III to II in the internal ribosome entry site of hepatitis C virus after interferon-ribavirin therapy. Ogata K; Kashiwagi T; Iwahashi J; Hara K; Honda H; Ide T; Kumashiro R; Kohara M; Sata M; Watanabe H; Hamada N Arch Virol; 2008; 153(8):1575-9. PubMed ID: 18592133 [TBL] [Abstract][Full Text] [Related]
17. Recent advances in the discovery of small molecule therapies for HCV. Myles DC Curr Opin Drug Discov Devel; 2001 Jul; 4(4):411-6. PubMed ID: 11727306 [TBL] [Abstract][Full Text] [Related]
18. Mathematical modeling of HCV infection and treatment. Dahari H; Shudo E; Ribeiro RM; Perelson AS Methods Mol Biol; 2009; 510():439-53. PubMed ID: 19009281 [TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus virology and new treatment targets. Meier V; Ramadori G Expert Rev Anti Infect Ther; 2009 Apr; 7(3):329-50. PubMed ID: 19344246 [TBL] [Abstract][Full Text] [Related]
20. Serine protease inhibitors as anti-hepatitis C virus agents. Reiser M; Timm J Expert Rev Anti Infect Ther; 2009 Jun; 7(5):537-47. PubMed ID: 19485794 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]